Skip to main content
OpenTrials
Completed

NCT Number: NCT04357262

Resiliency in Total Joint Arthroplasty

The investigators primary objective is to determine how does participation in StreaMD affect patient reported outcomes after Total Hip Arthroplasty (THA) or Total Knee Arthroplasty (TKA)?

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Osteoarthritis Arthritis Joint Diseases Musculoskeletal Diseases Rheumatic Diseases

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Utah Orthopaedic Center

Salt Lake City, Utah, 84108, United States

About this study

Osteoarthritis is a leading cause of disability in the US. By conservative estimates, about 54 million adults in the US have doctor-diagnosed arthritis. The number of people expected to have arthritis by the year 2040 is more than 78 million. Total joint arthroplasty is considered the treatment of choice for end-stage osteoarthritis. Currently, more than 1 million hip and knee replacements are performed each year in the US. By 2030, primary THR is projected to grow 171% and primary TKR is projected to grow by up to 189%, for a projected 635,000 and 1.28 million procedures, respectively. The incidence of pre-operative psychological distress in this group of patients is reported between 30% and 60% and preoperative psychological distress is associated with poorer pain and functional outcomes after surgery. Resilience, characterized by an ability to bounce back or recover from stress, is increasingly recognized as a psychometric property affecting many outcomes' domains including outcomes after TJA. Better resilience could improve patients overall satisfaction with the procedure.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients aged 18 and older who are receiving a total hip or knee replacement.

Exclusion criteria

  • Patients enrolled in the MyMobility study
  • Patients who do not have cell phones with text messaging capability
  • Non-English speaking patients

Treatment and study plan

StreaMD

Other

Patients who are randomized to the intervention arm will be signed up for the automated text messaging program. Patients will receive automated text messages related to their surgery during the study period and can also ask questions through the text messages program, where automated messages will be sent based on the questions asked.

Primary outcomes

  1. Patient Reported Outcome Score (PROMIS) following THA or TKA

    Time frame: Follow Up Visits up to 2-Years

    Patient reported outcome will consist of the Patient-Reported Outcomes Measurement Information System (PROMIS)

  2. Patient Reported Outcome Score (HOOS Jr.) following THA or TKA

    Time frame: Follow Up Visits up to 2-Years

    Patient reported outcome will consist of the hip disability and osteoarthritis outcome score (HOOS Jr.)

  3. Patient Reported Outcome Score (KOOS Jr.) following THA or TKA

    Time frame: Follow Up Visits up to 2-Years

    Patient reported outcome will consist of the knee injury and osteoarthritis outcome score (KOOS Jr.)

Sponsors and collaborators

Lead sponsor

University of Utah

Other

Registry information

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Apr 22, 2020
Registry last updated
Jul 15, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.